Assessing miRNAs profile expression as a risk stratification biomarker in oral potentially malignant disorders: A systematic review

The current evidence to support or refute the prognostic utility of miRNAs in predicting cancer progression in OPMDs is equivocal. Further longitudinal prospective studies with solid study design are warranted.